Through this collaboration, the two organisations will mutually-selected CVI research and development projects with the goal of commercializing them and resulting intellectual property.

CDRD Ventures (CVI), the commercialization vehicle of the Canada-based Centre for Drug Research and Development (CDRD), and US-listed drugs maker Pfizer have extended an investment fund supporting projects with therapeutic potential stemming from academic discovery.

Through this collaboration, the two organisations will mutually-selected CVI research and development projects with the goal of commercializing them and resulting intellectual property.

In 2007, Pfizer Canada invested in a Pfizer-CDRD Innovation Fund to support academic commercialization and the latest partnership is an extension to…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?